You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 17, 2025

Profile for Slovenia Patent: 2404593


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 2404593

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jun 2, 2029 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
⤷  Get Started Free Jan 27, 2026 Harrow Eye VERKAZIA cyclosporine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Slovenia Patent SI2404593

Last updated: August 9, 2025


Introduction

Patent SI2404593, granted in Slovenia, pertains to a pharmaceutical invention whose scope, claims, and landscape significantly influence its competitive positioning within the global drug patent arena. To facilitate strategic decision-making, it is essential to dissect the patent’s scope—particularly its claims—and understand its standing within the broader patent landscape.


Overview of Patent SI2404593

The patent was granted for a drug-related invention, reflecting innovation in formulation, method of use, or composition. While Slovenian patents often mirror broader European or international applications, this document’s specifics depend on territorial claims, the novelty, inventive step, and industrial applicability as adjudicated by the Slovenian Intellectual Property Office.


Scope of the Patent: Claims and Their Breadth

Claims Analysis

Legal Scope:
Claims define the legal boundaries of the patent. Typically, they are divided into independent and dependent claims:

  • Independent Claims: Describe the core inventive concept – possibly a novel formulation, method of synthesis, or therapeutic use.
  • Dependent Claims: Add specific limitations or embodiments, providing fallback positions or narrower protections.

Scope Characteristics:

  • If broad in language, such as claims covering “a pharmaceutical composition comprising compound X with any carrier,” the patent offers extensive monopoly rights.
  • If narrow, targeting specific compounds, dosages, or use cases, the scope is limited but precise.

Evaluation:
Without direct access to the exact claims text (which requires a patent document review), typical analysis involves assessing whether the claims encompass:

  • Specific chemical entities or classes (e.g., particular heterocycles, peptides).
  • Methods of manufacturing or formulations.
  • Therapeutic indications or methods of treatment.

Potential Claim Strategies:
The patent likely employs a mix of broad claims (e.g., covering a new class of compounds or a novel method for their synthesis) and narrower claims (specific molecules, doses, or methods). Such layering enhances legal robustness and enforceability.

Claim Clarity and Novelty

  • Clarity influences enforceability, especially if claims are ambiguous or overly broad.
  • Novelty hinges on whether prior art discloses similar compositions, methods, or uses.
  • Inventive step assessments consider whether the claims represent a non-obvious advance over existing knowledge.

Patent Landscape and Legal Status

National and International Positioning

While SI2404593 protects within Slovenia, its impact depends on corresponding jurisdictional patents or filings:

  • European Patent System:
    If there are EP filings claiming priority or priority extensions, the patent’s scope spans the EU and associated countries.

  • Patent Families:
    The presence of family members in major markets (e.g., US, China, Japan) indicates broader protection; absence limits global exclusivity.

  • Potential for Patent Challenges:
    The rights could face challenges based on prior art or patentability arguments, especially if broad claims are weak or overlapping existing patents.

Legal and Competitive Landscape

  • Overlap with Existing Patents:
    The patent’s novelty and inventive step depend on prior art, including earlier patents, scientific publications, or known formulations.

  • Expiration Timeline:
    Typically, pharma patents grant 20 years of protection from the filing date, subject to maintenance fees. Identification of filing date is crucial for estimating expiry.

  • Related Patents and Patent Thickets:
    The presence of multiple overlapping patents in similar therapeutic areas could affect freedom-to-operate and licensing strategies.


Implications for Stakeholders

For Innovators and Applicants:

Understanding claim scope helps in drafting robust patents that prevent workarounds and ensure global enforceability.

For Generic Manufacturers:

Analyzing claim breadth can reveal potential pathways for designing around the patent or identifying invalidating prior art.

For Investors and Business Strategists:

The patent landscape’s breadth indicates market exclusivity potential and competitive risks.


Legal Status and Enforcement Considerations

  • If SI2404593 has been maintained properly with up-to-date maintenance fees, it remains enforceable.
  • The patent’s adherence to formalities and lack of legal challenges strengthens its enforceability.
  • Its geographic scope remains limited unless extended through regional patents.

Conclusion and Future Outlook

Patent SI2404593’s scope hinges on its claim language, with the potential for broad or narrow protection. Its position within Slovenia’s patent landscape reflects strategic innovation—possibly a novel drug or formulation—bearing significant commercial implications within the EU and beyond. Continued monitoring for legal challenges or patent extensions will determine its durability and impact.


Key Takeaways

  • Precise analysis of claim language is essential for assessing patent strength and scope.
  • Broader claims offer more protection but risk invalidation if overly generic or anticipated.
  • Patent landscape position depends on filing strategies and family members in other jurisdictions.
  • Ongoing legal and regulatory examinations could influence patent enforceability.
  • Strategic lifecycle management, including potential extensions and challenge readiness, is critical to maximizing exclusivity.

FAQs

1. What is the primary focus of patent SI2404593?
The patent covers a specific pharmaceutical composition, method of synthesis, or therapeutic application related to a novel drug candidate in Slovenia. (Exact claims details depend on official patent documents.)

2. Can this patent be enforced outside Slovenia?
Not directly. Enforcement relies on corresponding patents in other jurisdictions. Validation or extension strategies are essential for international protection.

3. How does claim scope influence patent strength?
Broader claims offer wider legal protection but risk invalidation if they encompass prior art; narrow claims provide focused protection but may be easier to design around.

4. Is the patent susceptible to challenges?
Yes, if prior art shows similar inventions or if the claims are overly broad or unclear, the patent could face invalidation or licensing disputes.

5. What should companies consider for patent landscape analysis?
Identify related patents, assess overlapping claims, monitor patent expiration dates, and evaluate potential infringing or invalidating prior art.


Sources

[1] Slovenian Intellectual Property Office. Patent SI2404593 documentation.
[2] European Patent Office. Patent family and extension data.
[3] World Intellectual Property Organization. Patent landscape analysis tools and resources.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.